TSE
This article was originally published in The Tan Sheet
Executive Summary
FDA's TSE Advisory Committee will examine interim results of new study on inactivation of infective agent by gelatin manufacturing processes June 29 at Holiday Inn, Bethesda, Md., from 8:00 a.m. to 11:30 a.m
|
FDA's TSE Advisory Committee will examine interim results of new study on inactivation of infective agent by gelatin manufacturing processes June 29 at Holiday Inn, Bethesda, Md., from 8:00 a.m. to 11:30 a.m. |